Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

Fabrice Journé

Department : Laboratory of Oncology and Experimental Surgery (LOCE)
 
fabrice.journe [at] bordet.be

Publications

Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.

Authors : Yanni A, Buset T, Bouland C, Loeb I, Lechien JR, Rodriguez A, Journe F, Saussez S, Dequanter D
Year : 2022
Journal : Eur Arch Otorhinolaryngol

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.

Authors : Najem A, Soumoy L, Sabbah M, Krayem M, Awada A, Journe F, Ghanem GE
Year : 2022
Journal : Cells

Immune Cell Density Evaluation Improves the Prognostic Values of Staging and p16 in Oropharyngeal Cancer.

Authors : Descamps G, Furgiuele S, Mhaidly N, Journe F, Saussez S
Year : 2022
Journal : Cancers (Basel)

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.

Authors : Kehagias P, Kindt N, Krayem M, Najem A, Agostini G, Acedo Reina E, Bregni G, Sclafani F, Journe F, Awada A, Ghanem GE, Hendlisz A
Year : 2022
Journal : Cells

Bufalin for an innovative therapeutic approach against cancer.

Authors : Soumoy L, Ghanem GE, Saussez S, Journe F
Year : 2022
Journal : Pharmacol Res

More publications »

Follow us!

Youtube

The New Jules Bordet Institute.

The New Jules Bordet Institute, located on the university campus of the ULB in Anderlecht, is ready and will soon welcome its first patients. A new state-of-the-art hospital entirely dedicated to the fight against cancer.